Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-class antimicrobial zempia is active against clinical bacterial isolates

May 16, 2011

New antiviral agent OBR-5-340 is active against coxsackievirus B3 and rhinovirus 5

May 13, 2011

First-in-human data reported on FAB Pharma's antibacterial agent MUT-056399

May 13, 2011

Snapshots: Promising preclinical data on ImmunoGen's anticancer agents IMGN-853 and IMGN-529

May 13, 2011

KAG-308 has beneficial effects in models of chronic colitis

May 12, 2011

Preclinical data disclosed on RDX-5791 for constipation

May 12, 2011

PEM antibiotic POL-7080 well tolerated in phase I study

May 12, 2011

Clinical trial tests effect of food, H2R blockade and vitamin C on GSK-1322322 pharmacokinetics

May 12, 2011

Preclinical safety data on FCFD-4514-S enable advancement to clinic for geographic atrophy

May 12, 2011

AZD-2066 reduces transient lower esophageal sphincter relaxations in healthy subjects

May 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.